This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
Menu
Follow UroToday
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mCRPC Treatment
          Charles Ryan, MD
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Neal Shore, MD, FACS
        • A Patient Journey
          Alicia Morgans, MD, MPH
          Charles J. Ryan, MD
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
  • Transformative Evidence
    • mCRPC
      • CARD Trial
      • PROfound Study
    • mHSPC
      • ENZAMET Trial
    • nmCRPC
      • PROSPER Trial
    • Advanced Prostate Cancer
      • HERO Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Videos
    • Conference Coverage and Experts Group
      • Interviews with Experts at Conferences
        • ASCO GU 2021 Bladder and Kidney Cancer
        • ASCO GU 2021 Prostate Cancer
        • ASCO 2019
        • ASCO 2020
        • ASCO GU 2020
        • ESMO 2020
      • Exclusive Collaborations
        • APCCC 2019
        • LUGPA Annual Meeting 2019
        • PCF 2019
        • SNMMI Curriculum
    • UroToday Exclusives
      • A Step Towards Personalized Medicine: PSMA PET Imaging in Prostate Cancer
      • Book Club
      • Clinical Trials in Progress
      • Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer
      • COVID-19 and Genitourinary Cancers Videos
      • Journal Club
      • Large Urology Group Practice Association (LUGPA)
      • Precision Medicine: PSMA Targeted Therapies in Progressive Metastatic Prostate Cancer Videos
    • Urologic Oncology
      • Prostate Cancer
        • Advances in Nuclear Medicine, PET, and Theranostics
        • Advanced Prostate Cancer
        • Cardiovascular Disease in Men with Prostate Cancer
        • CRPC with Bone Metastases
        • The Expert Voice
        • Imaging: Prostate Cancer
        • Localized Prostate Cancer
        • mCRPC
        • mHSPC
        • Molecular Diagnostics
        • Navigating Cancer
        • nmCRPC
        • The Patient Voice
        • Precision Medicine in Prostate Cancer
        • Prostate Cancer
      • Right Group
        • Bladder Cancer
          • Bladder Cancer
          • Bladder Cancer Expert Debates
          • Advanced Bladder Cancer
          • Non-Muscle Invasive Bladder Cancer
        • Kidney Cancer
          • Advanced Kidney Cancer
          • Renal Cancer
        • Upper Tract Urothelial Tumors
          • Upper Tract Urothelial Carcinoma
        • Pelvic Health & Reconstruction
          • Bladder Health
          • Indwelling Catheters
          • Intermittent Catheters
          • Nocturia & Lower Urinary Tract Conditions
        • Endourology
          • Endourology Today
          • Endourology
  • Journals
    • Everyday Urology - Oncology Insights
      Everyday Urology - Oncology Insights
      • From the Editor
      • Current Issue
      • Previous Issues
    • Prostate Cancer and Prostatic Diseases
      Prostate Cancer and Prostatic Diseases
      • From the Editor
      • Current Article
      • Previous Articles
  • Clinical Trials
    • Clinical Trials
      • Search Clinical Trials
    • From the Editor
      • Current Letter
      • Previous Letters
  • Conference Coverage
    • Advanced Prostate Cancer Consensus Conference (APCCC)
      • 2019 APCCC Meeting
    • American Society of Clinical Oncology (ASCO)
      • 2021 ASCO GU Symposium
      • 2020 Virtual Education Program
      • 2020 Annual Meeting
      • 2020 ASCO GU Symposium
    • American Urological Association (AUA)
      • 2020 Annual Meeting
    • ANZUP Mini Annual Scientific Meeting (ASM)
      • 2020 Virtual Annual Meeting
    • Bladder Cancer Advocacy Network (BCAN)
      • 2020 Think Tank Virtual Program
    • EAU Section of Oncological Urology
      • ESOU 2021
    • EMUC
      • 2020 Annual Meeting
    • European Association of Urology (EAU)
      • 2020 Annual Congress
    • European Society for Medical Oncology (ESMO)
      • 2020 Virtual Congress
    • Global Society of Rare GU Tumors
      • 2020 Meeting
    • International Bladder Cancer Network (IBCN)
      • 2020 Annual Virtual Meeting
    • NMIBC - Drug Development 2021
      • 2021 Annual Meeting
    • Prostate Cancer Academy
      • 2020 Annual Meeting
    • Société Internationale d'Urologie (SIU)
      • 2020 Annual Congress
    • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
      • 2020 Congress
    • Society of Urologic Oncology (SUO)
      • 2020 Annual Meeting
      • 2020 SUO - AUA Summer Webcast
    • Targeted Alpha Therapy (TAT)
      • 2019 Symposium
  • Articles
    • Urologic Oncology
      • Adrenal Diseases
      • Bladder Cancer
      • CRPC w/ Bone Metastases
      • Penile Cancer
      • Prostate Cancer
      • Renal Cancer
      • Testicular Cancer
      • Upper Tract Tumors
      • Investigative Urology
    • Men's Health
      • Androgen Deficiency
      • BPH
      • Erectile Dysfunction
      • Male Infertility
      • Peyronie’s Disease
      • Prostatitis
      • Vasectomy
    • Pelvic Health & Reconstruction
      • Fecal Incontinence
      • Fistula
      • GU Trauma & Reconstruction
      • Indwelling Catheters
      • Infections
      • Intermittent Catheters
      • Interstitial Cystitis
      • Neurogenic Bladder
      • Nocturia
      • Overactive Bladder
      • Pelvic Prolapse
      • Post-prostatectomy Incontinence
      • Stress Incontinence
      • Underactive Bladder
      • Urethral Strictures
      • Urinary Incontinence
      • Urinary Retention
      • Urinary Tract Infection – CAUTIs
      • Urologic Catheters
    • Endourology & Urolithiasis
      • Minimally Invasive Procedures
      • Stone Disease
    • Pediatric Urology
      • Pediatric Urology
    • COVID-19 and Genitourinary Cancers
      • COVID-19 and Genitourinary Cancers
  • Calendar
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Investigative Urology

Recent Abstracts
Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis HMGA2 as a prognostic marker of bladder cancer - Abstract February 28, 2011
GU Cancers Symposium 2011: ASCO ASTRO SUO - Molecular characterization/individualization of prostate cancer - Session Highlights February 28, 2011
Development and validation of health beliefs model scale for prostate cancer screenings (HBM-PCS): Evidence from exploratory and confirmatory factor analyses - Abstract February 25, 2011
Long-term follow-up of HLA-A2+ patients with high-risk, hormone-sensitive prostate cancer vaccinated with the prostate specific antigen peptide homologue (PSA146-154) - Abstract February 24, 2011
A 20-gene model for molecular nodal staging of bladder cancer: Development and prospective assessment - Abstract February 24, 2011
Grape seed extract regulates androgen receptor-mediated transcription in prostate cancer cells through potent anti-histone acetyltransferase activity - Abstract February 23, 2011
Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression - Abstract February 23, 2011
The histone deacetylase inhibitor trichostatin a synergistically resensitizes a cisplatin resistant human bladder cancer cell line - Abstract February 23, 2011
Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis - Abstract February 22, 2011
Effects of bevacizumab on autocrine VEGF stimulation in bladder cancer cell lines - Abstract February 11, 2011
Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer - Abstract February 9, 2011
Excision repair cross-complementing group 1 (ERCC1) may predict the efficacy of chemoradiotherapy for bladder cancer - Abstract February 4, 2011
Receptor heterodimerization: A new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancer - Abstract February 3, 2011
The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine-cisplatin-based combination chemotherapy - Abstract February 3, 2011
FUS/TLS is a novel mediator of androgen-dependent cell cycle progression and prostate cancer growth - Abstract February 3, 2011
A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer - Abstract November 11, 2010
Page 346 of 346
  • Start
  • Prev
  • 337
  • 338
  • 339
  • 340
  • 341
  • 342
  • 343
  • 344
  • 345
  • 346
  • Next
  • End
  • About UroToday
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use

COPYRIGHT © 2002 - 2021 DIGITAL SCIENCE PRESS, INC.

Follow UroToday

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free